Galinpepimut-S

N/A

Report date: 2025/06/24 16:52:51

Base Information

Drug NameGalinpepimut-S
Drug Alias NameWT1 cancer vaccineWT-1 analog peptide vaccineWT1 peptide vaccineWT-1-analogue-peptide-vaccineGPS +[9] 
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesSmall Cell Lung CarcinomaLung Neoplasms +[19] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanPoland +[12] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesSellas Life Sciences Group3d Medicines IncMemorial Sloan Kettering Cancer Center +[5] 
Inactive CompaniesBelarusian State Medical UniversityNational Cancer InstituteThe University Of Texas MD Anderson Cancer Center
Active IndicationsMyelodysplastic SyndromesSmall Cell Lung CarcinomaHematologic Neoplasms +[12] 
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsAbdominal Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A